The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Abnormal Glucose tolerance-Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Abnormal Glucose Tolerance – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...
February 2021
60 pages
Advanced Urotheilal carcinoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Advanced Urothelial Carcinoma – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...
February 2021
60 pages
Alpha Thalassemia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Alpha Thalassemia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline...
February 2021
60 pages
Chronic Otitis Media (COM) - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Otitis Media (COM) - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+...
February 2021
60 pages
Chronic Pulmonary Infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Pulmonary Infections - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Chronic Traumatic Encephalopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Traumatic Encephalopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies...
February 2021
60 pages
Diabetic Cardiomyopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Diabetic Cardiomyopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pi...
February 2021
60 pages
Diabetic Ketoacidosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Diabetic Ketoacidosis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipe...
February 2021
60 pages
Egg allergy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Egg allergy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...
February 2021
60 pages
Endocarditis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Endocarditis – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drug...
February 2021
60 pages
ER+/ HER2 -ve Breast Cancer - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “ER+/ HER2 -ve Breast Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5...
February 2021
60 pages
Excessive Daytime Sleepiness - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Excessive Daytime Sleepiness - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Familial Mediterranean Fever - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Familial Mediterranean Fever - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
February 2021
60 pages
Gout - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Gout - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gou...
February 2021
60 pages
Hedgehog Pathway Inhibitors - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Hedgehog Pathway Inhibitors - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Hodgkin’s Lymphoma – Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Hodgkin’s Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipel...
February 2021
60 pages
Inflammatory Pain - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Inflammatory Pain - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
February 2021
60 pages
Inter Alpha Inhibitor Proteins - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Inter Alpha Inhibitor Proteins – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies an...
February 2021
60 pages
Lou Gehrig's Disease - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Lou Gehrig's disease – Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pip...
February 2021
60 pages
Lymphatic Malformations - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Lymphatic Malformations– Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pip...
February 2021
60 pages
MELAS Sundrome- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “MELAS Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline dr...
February 2021
60 pages
Metastatic Bone Pain- Pipeline insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Metastatic Bone pain – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pip...
February 2021
60 pages
Minimal Change Disease- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Minimal Change Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pip...
February 2021
60 pages
Molluscum Contagiosum - Pipeline Insight
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Molluscum Contagiosum - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pi...
February 2021
60 pages
Mucinous cystic neoplasm - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mucinous cystic neoplasm - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...
February 2021
60 pages
Nasal Polyposis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Nasal Polyposis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline d...
February 2021
60 pages
Natural Killer T Cell Lymphoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Natural Killer T Cell Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies an...
February 2021
60 pages
Necrobiosis Lipoidica - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Necrobiosis Lipoidica - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipe...
February 2021
60 pages
Necrotizing Enterocolitis – Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Necrotizing Enterocolitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+...
February 2021
60 pages
Netherton Syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Netherton Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipelin...
February 2021
60 pages
Niemann Pick C Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Niemann Pick C Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ p...
February 2021
60 pages
Opioid Withdrawal Syndrome-Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Opioid withdrawal syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+...
February 2021
60 pages
Palmoplantar Keratoderma- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Palmoplantar Keratoderma – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ p...
February 2021
60 pages
Palmoplantar Pustulosis- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Palmoplantar Pustulosis – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pi...
February 2021
60 pages
Pericarditis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pericarditis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drug...
February 2021
60 pages
